Authors
Loading...
Narrative review reveals hypoxia-inducible factor-1α dysregulation across inflammatory autoimmune diseases, suggesting novel therapeutic targets for conditions like lupus and rheumatoid arthritis.
Tang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: